Natalizumab treatment reduces microglial activation in the white matter of the MS brain.
Sucksdorff M, Tuisku J, Matilainen M, Vuorimaa A, Smith S, Keitilä J, Rokka J, Parkkola R, Nylund M, Rinne J, Rissanen E, Airas L.
Sucksdorff M, et al. Among authors: rissanen e.
Neurol Neuroimmunol Neuroinflamm. 2019 Jun 7;6(4):e574. doi: 10.1212/NXI.0000000000000574. eCollection 2019 Jul.
Neurol Neuroimmunol Neuroinflamm. 2019.
PMID: 31355310
Free PMC article.